We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
LivaNova
LIVN
$4.3B
| $168K | ﹤0.01% |
3,500
-16,100
| -82% | -$807K |
|
1677
Synaptics
SYNA
$4.41B
| $168K | ﹤0.01% |
2,800
+200
| +8% | +$12.5K |
|
1678
OneSpan
OSPN
$562M
| $167K | ﹤0.01% |
+6,000
| New | +$118K |
|
|
BRT
1679
BRT Apartments
BRT
$282M
| $166K | ﹤0.01% |
15,363
+95
| +0.6% | +$969 |
|
1680
Century Casinos
CNTY
$32.9M
| $166K | ﹤0.01% |
40,000
+3,300
| +9% | +$13.8K |
|
|
XENT
1681
DELISTED
Intersect ENT, Inc
XENT
| $166K | ﹤0.01% |
+12,300
| New | +$143K |
|
|
BAND
1682
Bandwidth Inc
BAND
$1.91B
| $165K | ﹤0.01% |
+1,300
| New | +$131K |
|
|
ESSA
1683
DELISTED
ESSA Bancorp
ESSA
| $165K | ﹤0.01% |
11,900
+1,000
| +9% | +$12.9K |
|
|
SLCT
1684
DELISTED
Select Bancorp, Inc.
SLCT
| $164K | ﹤0.01% |
20,200
+1,700
| +9% | +$12.8K |
|
1685
Ultrapar
UGP
$6.87B
| $162K | ﹤0.01% |
48,000
| – | – |
|
|
MIME
1686
DELISTED
Mimecast Limited
MIME
| $162K | ﹤0.01% |
+3,900
| New | +$153K |
|
1687
Relmada Therapeutics
RLMD
$544M
| $161K | ﹤0.01% |
+3,600
| New | +$152K |
|
1688
Merit Medical Systems
MMSI
$4.43B
| $159K | ﹤0.01% |
3,500
+1,400
| +67% | +$56.5K |
|
|
PARA
1689
DELISTED
Paramount Global Class B
PARA
| $159K | ﹤0.01% |
6,850
-134,746
| -95% | -$2.6M |
|
1690
Amalgamated Financial
AMAL
$1.48B
| $158K | ﹤0.01% |
12,500
+1,900
| +18% | +$20.1K |
|
1691
CVB Financial
CVBF
$3.98B
| $157K | ﹤0.01% |
8,400
-7,500
| -47% | -$143K |
|
1692
Avista
AVA
$3.47B
| $156K | ﹤0.01% |
4,300
-13,200
| -75% | -$523K |
|
1693
BridgeBio Pharma
BBIO
$16.5B
| $156K | ﹤0.01% |
+4,800
| New | +$146K |
|
1694
Oneok
OKE
$58.7B
| $155K | ﹤0.01% |
4,688
-7,606
| -62% | -$248K |
|
1695
Arcturus Therapeutics
ARCT
$157M
| $154K | ﹤0.01% |
+3,300
| New | +$114K |
|
|
PRVB
1696
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $153K | ﹤0.01% |
+10,900
| New | +$138K |
|
1697
Atlantic Union Bankshares
AUB
$5.99B
| $152K | ﹤0.01% |
6,600
+1,000
| +18% | +$22.5K |
|
|
BRSP
1698
BrightSpire Capital
BRSP
$681M
| $151K | ﹤0.01% |
21,600
| – | – |
|
1699
Omnicom Group
OMC
$22.7B
| $151K | ﹤0.01% |
2,773
| – | – |
|
|
DCOM
1700
DELISTED
Dime Community Bancshares
DCOM
| $151K | ﹤0.01% |
11,000
+900
| +9% | +$13K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.